Vendor, Durham, NC, part of G1 Therapeutics Inc.
G1 Therapeutics, Inc.
UEI L72RA25Z7LK3, CAGE 59AR1
1 award and $0 obligated between March 22, 2024 and March 21, 2025, 100% under full and open competition, against 999.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36F79721D0205March 22, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 65IB / Administrative Update: Alternate Point of Contact (Poc) & Signatory Authority (Sa) FormNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 3 across 1 awards